We are live on ! Find out more
EVFM

Evofem Biosciences, Inc. Common Stock
EVFM

Delisted

EVFM was delisted on the 10th of August, 2022.

Back to rankings

71 hedge funds and large institutions have $19.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more call options, than puts

Call options by funds: $2.04M | Put options by funds: $611K

12% less funds holding

Funds holding: 81 → 71 (-10)

32% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 19

45% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 20

52% less capital invested

Capital invested by funds: $40.8M → $19.8M (-$21M)

Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
19
Closed
20
Calls
$2.04M
Puts
$611K
Net Calls
+$1.43M
Net Calls Change
+$136K

Top Buyers

Rank Fund Capital Flow
1
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$905K
2
BlackRock
BlackRock
New York
+$396K
3
Bank of America
Bank of America
North Carolina
+$202K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$152K
5
SW
SteelPeak Wealth
California
+$50.3K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$3.3M
2
Millennium Management
Millennium Management
New York
-$2.53M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.7M
4
HA
Heartland Advisors
Wisconsin
-$1.24M
5
TWMP
Taylor Wealth Management Partners
Massachusetts
-$574K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
51
Gofen & Glossberg
Illinois
$7K +$8.38K +667 New
MWM
52
Modera Wealth Management
New Jersey
$7K +$8.38K +667 New
Wells Fargo
53
Wells Fargo
California
$3K -$25 -2 -0.7%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$1.65K -$377 -30 -17%
JP Morgan Chase
55
JP Morgan Chase
New York
$1K -$7.99K -636 -81%
AIM
56
Arcadia Investment Management
Michigan
$1K – – –
HWA
57
HHM Wealth Advisors
Tennessee
$1K – – –
Northwestern Mutual Wealth Management
58
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$1K – – –
US Bancorp
60
US Bancorp
Minnesota
$1K – – –
LTI
61
Laffer Tengler Investments
Tennessee
$169 +$188 +15 New
Renaissance Technologies
62
Renaissance Technologies
New York
– -$1.7M -100,526 Closed
HA
63
Heartland Advisors
Wisconsin
– -$1.24M -73,333 Closed
TWMP
64
Taylor Wealth Management Partners
Massachusetts
– -$574K -33,877 Closed
E
65
Ergoteles
New York
– -$395K -23,313 Closed
ECM
66
ExodusPoint Capital Management
New York
– -$134K -7,892 Closed
CSS
67
Cubist Systematic Strategies
Connecticut
– -$118K -6,958 Closed
TRCT
68
Tower Research Capital (TRC)
New York
– -$71K -4,211 Closed
LP
69
LMR Partners
United Kingdom
– -$54K -3,175 Closed
AQR Capital Management
70
AQR Capital Management
Connecticut
– -$36K -2,116 Closed
XT
71
XTX Topco
Cayman Islands
– -$24K -1,399 Closed
BFM
72
Boothbay Fund Management
New York
– -$23K -1,377 Closed
YIH
73
Y-Intercept (HK)
Hong Kong
– -$21K -1,254 Closed
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
– -$13.9K -1,107 -97%
Grantham, Mayo, Van Otterloo & Co (GMO)
75
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
– -$14K -855 Closed
1 2
3
4

EVFM Hedge Fund Activity: Q3 2021 in Review

71 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Evofem Biosciences, Inc. Common Stock (EVFM) for Q3 2021, worth a combined $19.8M — down 52% from $40.8M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of EVFM and 11 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 13 added.

The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $905K. The largest seller was Morgan Stanley, cutting an estimated $3.3M.

  • 71 institutional investors held Evofem Biosciences, Inc. Common Stock (EVFM) as of Q3 2021, down from 81 in Q2 2021.
  • Funds reported $19.8M of Evofem Biosciences, Inc. Common Stock stock for Q3 2021, down 52% quarter-over-quarter.
  • 11 funds opened new Evofem Biosciences, Inc. Common Stock positions in Q3 2021 and 20 closed out, a net change of -9 holders.
  • The largest Evofem Biosciences, Inc. Common Stock buyer in Q3 2021 was Fuller & Thaler Asset Management, an estimated $905K added.
  • The largest Evofem Biosciences, Inc. Common Stock seller in Q3 2021 was Morgan Stanley, an estimated $3.3M sold.

Based on aggregated 13F filings for Q3 2021.